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ABSTRACT OF THE THESIS 
Relationships between Age and White Matter Integrity in Children with Phenylketonuria 
by 
Erika Mayfield Wesonga 
Master of Arts in Psychology 
Washington University in St. Louis, 2015 
Professor Desiree White, Chair 
Objective: Phenylketonuria (PKU) is a hereditary metabolic disorder associated with cognitive 
compromise. Diffusion tensor imaging (DTI) has allowed detection of poorer microstructural 
white matter integrity in children with PKU, with decreased mean diffusivity (MD) in 
comparison with healthy children. However, very little research has been conducted to examine 
the trajectory of white matter development in this population. The present study investigated 
potential differences in the developmental trajectory of MD between children with early- and 
continuously-treated PKU and healthy children across a range of brain regions. 
Methods: Children with PKU (n = 31, mean age = 12.2 years) were recruited through metabolic 
clinics, and their MD findings across 10 brain regions of interest (ROIs) were compared with 
those of healthy control children (n = 51, mean age = 12.0 years). Hierarchical linear regressions, 
including age, group, and the age by group interaction, were performed on MD for each ROI. For 
ROIs with significant interactions, Pearson correlations between age and MD were obtained and 
compared across groups. 
v 
 
Results: The age by group interaction was significant for the splenium and genu of the corpus 
callosum, the optic radiation, and the hippocampus (p < 0.05 in all instances). The relationship 
between MD and age was significant for all 4 of these ROIs within the PKU group but none 
within the control group. In all instances, MD decreased as a function of increasing age. The 
relationship between age and MD was significantly different between the PKU and control 
groups for the optic radiation, hippocampus, and genu of the corpus callosum (z < -1.96 in all 
instances).  
Conclusions: A stronger age-related decrease in MD was identified for children with PKU in 
comparison with healthy children in 4 ROIs, indicating that the trajectory of white matter 
development is abnormal in children with PKU. Further research using longitudinal methodology 
is needed to fully elucidate our understanding of white matter development in PKU. 
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Introduction 
 Phenylketonuria (PKU) is an autosomal recessive metabolic disorder characterized by a 
dysfunctional or absent enzyme, phenylalanine hydroxylase (PAH), which is responsible for the 
metabolism of the amino acid phenylalanine (Phe). With little to no functional PAH, Phe 
accumulates in the blood and brain of individuals with PKU (De Groot, Hoeksma, Blau, 
Reijngoud, & Van Spronsen, 2010). Dietary restriction of foods with high Phe (i.e., high protein 
foods) such as beans, dairy, and meats is necessary to maintain Phe levels within clinically 
recommended ranges. To maintain adequate protein requirements, the PKU diet is supplemented 
with drinkable Phe-free formulas.    
If untreated, PKU typically has devastating consequences, including severe intellectual 
disability (Mitchell, Trakadis, & Scriver, 2011; Paine, 1957). Widespread newborn screening 
programs implemented in the 1960s largely eradicated the incidence of untreated cases in 
developed nations. However, even when PKU is diagnosed early and treated continuously, 
affected individuals demonstrate poorer mood, psychosocial functioning, academic achievement, 
and psychiatric outcomes compared with the general population (Enns et al., 2010; Moyle, Fox, 
Arthur, Bynevelt, & Burnett, 2007; Van Spronsen, Huijbregts, Bosch, & Leuzzi, 2011). In 
addition, individuals with early- and continuously-treated PKU exhibit lower IQ (Ris, Williams, 
Hunt, Berry, & Leslie, 1994) and subtle cognitive deficits, particularly in executive abilities such 
as working memory, inhibitory control, and strategic processing (Christ, Huijbregts, de 
Sonneville, & White, 2010; DeRoche & Welsh, 2008; Moyle, Fox, Arthur, Bynevelt, & Burnett, 
2007). Recent work has demonstrated that both elevated Phe levels and greater variability in Phe  
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levels are associated with poorer IQ and executive performance in the early- and continuously-
treated PKU population (Hood, Grange, Christ, Steiner, & White, 2014). 
In terms of brain mechanisms that may underlie PKU-related deficits, a deficiency in the 
neurotransmitter dopamine has long been hypothesized as the primary factor (De Groot et al., 
2010). In healthy individuals, the action of PAH converts Phe into tyrosine, which is a precursor 
of dopamine and other catecholaminergic neurotransmitters. When this metabolic pathway is 
disrupted in individuals with PKU, lower levels of dopamine are observed (Scriver, 2007). 
Dopaminergic projections to the prefrontal cortex are crucial to a number of frontally-mediated, 
higher-order abilities, including working memory, response inhibition, attention, and cognitive 
flexibility (Diamond & Baddeley, 1996; Volkow et al., 1998). It is likely that the impact of 
reduced dopamine on this cognitive skill set contributes to the poorer functional outcomes 
observed in individuals with early- and continuously-treated PKU.   
Of particular relevance to the current study, recent PKU research has increasingly 
investigated the white matter of the brain, which facilitates the efficient flow of information 
between interconnected brain regions. Past studies using structural magnetic resonance imaging 
(MRI) have identified decreased white matter volume and hyperintensities in the white matter  
that primarily occur in periventricular brain regions (Anderson et al., 2004; Cleary et al., 1995; 
Leuzzi et al., 1993; Manara et al., 2009; Thompson et al., 1993). This structural imaging 
approach, however, is not ideal for studying individuals with early- and continuously-treated 
PKU because gross white matter abnormalities are rarely observed in this group. In addition, the  
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majority of structural MRI studies have used a qualitative approach to categorize rather than 
quantify white matter abnormalities.   
In recent years, diffusion tensor imaging (DTI) has been used as a more refined 
quantitative MRI approach to investigate white matter pathology in individuals with PKU 
(Antenor-Dorsey et al., 2013; Peng, Peck, White, & Christ, 2013; White et al., 2010; White et al., 
2013). DTI provides information regarding the microstructural integrity of the white matter by 
measuring the movement, or diffusion, of water molecules (Sener, 2004). Two DTI measures are 
frequently reported: (1) fractional anisotropy (FA), which reflects the degree of asymmetry of 
water diffusion and (2) mean diffusivity (MD), which reflects the overall spatial average rate of 
water diffusion.  
In studies of individuals with PKU, normal FA but reduced MD has been consistently 
reported (Dezortova, Hajek, Tintěra, Hejcmanova, & Sykova, 2001; Kono et al., 2005; White et 
al., 2013), suggesting restricted diffusion within axons. Reduced MD in individuals with early- 
and continuously- treated PKU has been associated with higher blood Phe levels, as well as 
increased variability in blood Phe levels (Hood et al., 2015). With regard to cognition, reduced 
MD has also been associated with lower IQ and poorer performance on executive tasks 
(Antenor-Dorsey et al., 2013; Vermathen et al., 2007; White et al., 2010).  
From a developmental perspective, there is limited knowledge regarding the age-related 
trajectory of MD in individuals with PKU. In healthy children, a sharp increase in MD is 
typically observed in the months after birth, followed by a decrease in MD until middle 
childhood, at which time a plateau is generally reached and maintained until the elderly stages of  
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life (Lebel, Walker, Leemans, Phillips, & Beaulieu, 2008; Snook, Paulson, Roy, Phillips, & 
Beaulieu, 2005). In relation to our population of interest, White et al. (2010) observed an age-
related decrease in MD in anterior regions of the corpus callosum in children with early- and 
continuously-treated PKU, but this is the only DTI study in which white matter integrity has 
been examined in PKU from a developmental perspective.  
The present study was conducted to more thoroughly investigate the developmental 
trajectory of MD in children with early- and continuously-treated PKU across a range of brain 
regions. We hypothesized that increasing age would be more strongly associated with decreasing 
MD in children with PKU compared with healthy children. To investigate this hypothesis, we 
examined MD in relation to age across 10 brain regions in school-aged children with early- and 
continuously-treated PKU and demographically matched healthy control children.  
Methods 
Participants 
Participants were children with PKU (n = 31; 16 girls, 15 boys) and healthy control 
children (n = 51; 26 girls, 25 boys) recruited in conjunction with a longitudinal study funded by 
the National Institute of Child Health and Human Development (R01 HD0449901). Children 
with PKU were recruited through the Division of Genetics and Genomic Medicine in the 
Department of Pediatrics at St. Louis Children’s Hospital and Washington University in St. 
Louis, Missouri (WUSTL) and through the Metabolic Clinic at the Child Development and 
Rehabilitation Center at Doernbecher Children’s Hospital and Oregon Health & Science 
University in Portland, Oregon (OHSU). All children with PKU were diagnosed soon after birth  
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and received early and continuous treatment through dietary management of Phe intake. Phe 
levels over the lifetime were provided by the referring metabolic clinics and ranged from 230 - 
1574 µmol/L (M = 530.2 SD = 334.9). Healthy control children were recruited from the St. 
Louis and Portland communities.  
The age of children in both groups ranged from 7 to 18 years (PKU: M = 12.2, SD = 3.9; 
Control: M = 12.0, SD = 3.3). Education ranged from 1 to 13 years for the PKU group (M = 6.4, 
SD = 3.6) and 1 to 14 years for the control group (M = 6.2, SD = 3.4). IQ ranged from 86 to 139 
for the PKU group (M = 106.8 SD = 11.3) and 84 to 143 for the control group (M = 115.2, SD = 
14.8). Chi square and t-test analyses revealed no significant between-group differences in 
gender, age, or education (p > 0.05 in all instances), but IQ was significantly lower for the PKU 
than control group (p < 0.01). No child had a history of intellectual disability, learning disorder, 
or major medical disorder unrelated to PKU.  
Procedure 
Approval to conduct the study was obtained from Human Research Protection Offices at 
WUSTL and OHSU. Informed consent and assent were obtained from all participants and their 
guardians before administration of any study procedures. A cognitive battery was administered 
as part of a larger study, but measures from this battery were not analyzed for this report.  
Neuroimaging 
Structural images were acquired on a Siemens TIM Trio 3.0 T imaging system (Erlangen, 
Germany) with a standard Siemens 12 channel head coil. These images included a T1-weighted  
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(T1W) sagittal, magnetization-prepared rapid gradient echo [MPRAGE; repetition time (TR) = 
2000 ms, echo time (TE) = 3.03 ms (WU), flip angle = 8°, FOV = 256 × 256 pixels, voxel 
resolution = 0.88 × 0.88 × 0.9 mm and a T2-weighted (T2W) fast spin echo [TR = 3200, TE = 
475, flip angle = 120°, FOV = 256 × 256 pixels, voxel resolution = 0.88 × 0.88 × 0.9 mm]. DTI 
was acquired using an echo planar imaging (EPI) sequence [TR = 12,437 (WU) and 9900 (UM), 
TE = 102 (WU and UM), flip angle = 90° (WU and UM), FOV = 864 × 864 (WU) and 768 × 
768 (UM), voxel resolution = 2.0 × 2.0 × 2.0 (WU and UM)]. Diffusion weighted images (DWI) 
with variable b factor up to 1000 s/mm2 maximum were acquired along 25 non-collinear 
diffusion gradient orientations. DWIs were registered first to the b = 0 unsensitized image, then 
to the T2W, then to the best T1W (MPRAGE), and finally to a WUSTL in-house atlas.  
MD region of interest (ROI) analyses were conducted across a sampling of 10 brain 
regions, including: prefrontal cortex, centrum semiovale, posterior parietal-occipital cortex, optic 
radiation, putamen, corpus callosum (CC; genu, body, splenium), thalamus, and hippocampus. 
The diffusion tensor and its three eigenvalues were calculated using log-linear regression in each 
voxel for each ROI. Using standard methods, MD was computed as the average of the three 
eigenvalues, and a parametric map was then generated for MD. ROIs were then applied to each 
participant's MD parametric map and sampled using Analyze version 8.0 (Mayo Clinic, 
Rochester). Values from left and right homologous regions were averaged. The mean and 
standard deviation (SD) of MD for each ROI are listed in Table 1. 
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Statistical Analyses 
As a starting point, t-tests were used to determine whether MD across the 10 ROIs 
differed between the PKU and control groups. Results were considered significant if p < .05.  
Hierarchical linear regressions were then performed to determine the proportion of variance in 
MD for each ROI that was accounted for by age, group, or the interaction between age and 
group. Age was entered in the first step, followed by group (PKU, control), followed by the age 
by group interaction. The interaction between age and group was of particular interest in terms 
evaluating whether the relationship between age and MD differed for PKU and control groups. 
Pearson correlations between age and MD for each group were then obtained to further explore 
significant age by group interactions revealed by linear regression. Because the sampling 
distribution of correlations was not normally distributed (ρ ≠ 0), Fisher R→Z transformations 
were conducted for each correlation. A z-test of significance was used with the resulting 
statistics to determine whether the correlation between age and MD significantly differed 
between the PKU and control groups. Between-group differences were considered significant if 
p < 0.05 (i.e., z < -1.96)  
Results 
The mean and standard deviation (SD) of MD for each ROI are listed in Table 1, along 
with statistical findings from t-tests examining between-group differences in MD. Significant 
between-group differences in MD were found for the genu of the CC, centrum semiovale, and 
posterior parietal occipital cortex. In all instances, MD for the PKU group was lower than for the 
control group.  
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With respect to the relationships between age and MD, statistical findings from 
hierarchical linear regressions are reported in Table 2. Age accounted for a significant proportion 
of the variance in MD for all ROIs except the genu of the CC. After considering the variance 
attributable to age, group accounted for a significant proportion of the variance in MD for the 
genu of the CC, centrum semiovale, posterior parietal occipital cortex, hippocampus, and 
thalamus. Of greater interest, the interaction between age and group accounted for a significant 
proportion of the variance in MD for the splenium and genu of the CC, the optic radiation, and 
the hippocampus.  
Correlation analyses were used to further explore these significant interactions. As shown 
in Table 3, the relationship between age and MD was significantly different (z < -1.96) between 
the PKU and control groups for the genu of the CC, optic radiation, and hippocampus, with 
significant correlations for the PKU group but not the control group; although no significant 
between-group difference in correlations was found for the splenium, the pattern of correlations 
trended in the same direction. In fact, across the genu and splenium of the CC, the optic 
radiation, and the hippocampus, all correlations between age and MD were significant for the 
PKU group but not the control group, such that MD decreased as a function of increasing age for 
the PKU group.   
Discussion 
 Subtle cognitive compromise in children with early-and continuously treated PKU has 
been associated with both gross structural (Anderson et al., 2004) and microstructural (Antenor-
Dorsey et al., 2013) white matter abnormalities in the brain. Of particular relevance to the current  
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research, a number of studies have shown that MD across a range of brain regions is lower in 
children with early-and continuously treated PKU in comparison with healthy controls (Kono et 
al., 2005; White et al 2010), but little is known about the developmental trajectory of MD in this 
population. As such, the current study was conducted to assess whether the relationship between 
age and MD was different between children with PKU and healthy control children (in whom 
age-related decreases in MD generally plateau by middle childhood).  
Results from hierarchical linear regressions provided evidence that the relationship 
between age and MD differed between these groups. More specifically, after considering the 
variance attributable to age and group, the interaction between age and group accounted for a 
significant proportion of the variance in MD for the splenium and genu of the CC, optic 
radiation, and hippocampus. Further correlation analyses showed that, in these four ROIs, MD 
decreased as a function of increasing age for the PKU group but not the control group.  
It is interesting to consider the specific brain regions in which age-related decreases in 
MD were observed for the PKU group. Turning first to the optic radiation, although few human 
studies have been conducted on the development of this white matter tract, the available 
evidence suggests that it reaches maturity within the first few years of life in healthy children 
(Yamada et al., 2000).  Thus, in comparison, children with early- and continuously-treated PKU 
demonstrated substantially protracted developmental changes in this tract.  
In contrast with the optic radiation, the white matter of the hippocampus and CC 
continues to mature into the second decade of life in healthy individuals (Benes et al 1994; 
Eluvathingal et al., 2007; Giorgio et al. 2008; Lebel et al. 2008; Lebel et al, 2010; Miller et al,  
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2003; Tamnes et al. 2010). Diffusion measures of the CC generally have greater noise due to 
their close proximity with cerebrospinal fluid (Mukherjee et al., 2001), which could mask subtle 
maturational changes. Nonetheless, we observed a decrease in MD in the splenium and genu of 
the CC as a function of increasing age for the PKU group but not the control group, suggesting 
that this differential decrease is robust. With regard to the hippocampus, decreases in MD in this 
region slow with increasing age for healthy individuals (Tamnes et al. 2010), but again MD 
decreased to a greater extent in children with PKU.  
Collectively, these observations indicate that microstructural white matter development is 
disrupted in children with early- and continuously-treated PKU across a variety of brain regions. 
Specifically, there is an abnormal restriction of water diffusion in the white matter that increases 
as children with PKU age. Although beyond the scope of the current investigation, future 
research elucidating the impact of disruptions in white matter development on functional 
outcomes (e.g., neurocognitive, social, psychiatric outcomes) in children with PKU will be 
crucial. In addition, longitudinal research will be important to investigate potential differences in 
growth curves of MD between healthy children and children with PKU.  
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 Tables 
 
Table 1: Mean (SD) for MD of ROIs  
ROI 
MD 
Control PKU t  p 
Splenium of the CC 0.79(0.04) 0.79(0.07) 0.12 0.91 
Genu of the CC 0.86(0.06) 0.82(0.08) 2.56 0.01* 
Body of the CC 0.96(0.08) 0.93(0.13) 1.13 0.26 
Optic Radiation 0.85(.04) 0.85(0.06) 0.33 0.74 
Centrum Semiovale 0.77(0.03) 0.75(0.04) 2.33 0.02* 
Prefrontal cortex 0.77(0.03) 0.78(0.04) -0.53 0.60 
Post Parietal Occipital 0.81(0.04) 0.77(0.05) 3.08 0.00* 
Hippocampus 0.91(0.03) 0.93(0.05) -1.80 0.08 
Thalamus 0.81(0.03) 0.82(0.04) -1.91 0.06 
Putamen 0.76(0.02) 0.76(0.03) 0.11 0.91 
Note: * p < .05 and medium or large effect size; df = 80 for all analyses. Given a priori 
hypotheses, all t tests were 1-tailed.  
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Table 2.  Statistical findings from hierarchical linear regressions examining the variance in MD attributable to age, 
group, and the age x group interaction.   
ROI 
Age Group Age x Group 
R2 F p ∆R2 ∆F p ∆R2 ∆F p 
Splenium of the CC 0.12 10.61 0.01*  0.00 0.00 0.97  0.05 4.22 0.04* 
Genu of the CC 0.04 2.90 0.09  0.07 6.47 0.01*  0.09 8.44 0.01* 
Body of the CC 0.20 19.38 0.01*   0.02 1.65 0.20   0.00 0.09 0.77 
Optic Radiation 0.11 10.25 0.01* 0.00 0.09 0.77 0.07 6.60 0.01* 
Centrum Semiovale 0.44 63.74 0.01* 0.07 10.62 0.01* 0.02 2.68 0.11 
Prefrontal White Matter 0.18 17.04 0.01* 0.01 0.57 0.45 0.01 0.97 0.33 
Post Parietal Occipital 0.36 45.68 0.01* 0.11 16.91 0.01* 0.02 3.63 0.06 
Hippocampus 0.20 19.37 0.01* 0.05 5.70 0.02* 0.06 6.56 0.01* 
Thalamus 0.21 20.74 0.01*  0.05 5.16 0.03*  0.01 0.82 0.37 
Putamen 0.27 30.14 0.01*  0.00 0.00 0.99  0.00 0.03 0.86 
Note: * p < 0.05. 
Table 3. Correlations and between-group differences in correlations between age and MD 
for the PKU and control groups.  
ROI 
Correlation between age and MD 
    Group    
differences  
Control PKU z-score 
Splenium of the CC -0.17 -0.51* -1.64 
Genu of the CC 0.10 -0.49* -2.68* 
Optic Radiation -0.11 -0.55* -2.13* 
Hippocampus -0.21 -0.62* -2.17* 
Note: * p < 0.05. 
  
 
